Home sample collection tests for HIV infection

JAMA

Volumn 280, Issue 19, 1998, Pages 1699-1701

  Branson, Bernard M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BISEXUALITY; DIAGNOSTIC TEST; FEMALE; HOME MONITORING; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0032544999     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.19.1699     Document Type: Article

References (10)

1. Bayer R, Stryker J, Smith MD. Testing for HIV infection at home. N Engl J Med. 1995;332:1296-1299.
2. Skelley M. Testimony on behalf of the Association of State and Territorial Health Officials, Council of State and Territorial Epidemiologists, National Alliance of State and Territorial AIDS Directors, Association of State and Territorial Public Health Laboratory Directors, FDA Blood Products Advisory Committee; June 22, 1994; Washington, DC.
3. Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA. 1996; 276:126-131.
4. Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funded Sites: 1995 Summary Report. Atlanta, Ga: US Dept of Health and Human Services; 1997.
5. Schopper D, Vercauteren G. Testing for HIV at home: what are the issues? AIDS. 1996;10:1255-1265.
6. Colfax GJ, Lehman J, Hecht FM, et al. Likelihood of at-risk individuals using home HIV test collection kits. Paper presented at: Society of General Internal Medicine, 20th Annual Meeting; May 2, 1997; Washington, DC.
7. Hoxie NJ, Vergeront JM, Pfister JR, et al. Improving estimates of HIV-1 seroprevalence among child-bearing women: use of smaller blood spots. Am J Public Health. 1992;82:1370-1373.
8. Malor CJ, Read SE, Coates RA, et al. Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis. 1991;163:699-702.
9. Schultz WB. Advisory Opinion. Washington, DC: US Food and Drug Administration; 1996.
10. Kassler WJ. Advances in HIV testing technology and their potential impact on prevention. AIDS Educ Prev. 1997;9(suppl B):27-40.